Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
34,630,592
-
Share change
-
-572,920
-
Total reported value
-
$660,414,393
-
Put/Call ratio
-
193%
-
Price per share
-
$19.07
-
Number of holders
-
142
-
Value change
-
-$12,882,656
-
Number of buys
-
76
-
Number of sells
-
53
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2016
As of 30 Jun 2016,
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,630,592 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, STATE STREET CORP, Point72 Asset Management, L.P., FMR LLC, BlackRock Fund Advisors, venBio Select Advisor LLC, BlackRock Institutional Trust Company, N.A., JENNISON ASSOCIATES LLC, and MORGAN STANLEY.
This page lists
142
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.